Flash Therapeutics Company
Flash is developing an oral compound to prevent AML relapse.
Technology:
Others
Industry:
P4 Medicine
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2018
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
5000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership